Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: A five-year follow-up
References (9)
- et al.
Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12
Int J Radiat Oncol Biol Phys
(1993) - et al.
Baccillus Calmette-Guérin therapy for superficial bladder cancer: a 10-year follow-up
J Urol
(1992) - et al.
Durability of the tumor-free response for intravesical bacillus Calmette-Guérin therapy
J Urol
(1994) - et al.
Bladder-sparing approach in the treatment of invasive bladder cancer
Semin Urol
(1990)
There are more references available in the full text version of this article.
Cited by (77)
A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer
2018, Urologic Oncology: Seminars and Original InvestigationsCitation Excerpt :Likewise, in studies that used a radiation dose of 60–66 Gy [7,9,11,20,22,26,28,30,34,41,42], there was no difference in the rate of CR for TMT studies using a radiation dose ≥60 Gy vs.<60 Gy (71.7% vs. 71.2%, P = 0.49) [25,29,31,35,36,39]. In TMT studies that used NAC plus TMT [7,8,23,24,38], the mean CR was not significantly higher for TMT plus NAC compared to TMT alone (76.2% vs. 73.0%, P = 0.33) [10,11,20–22,25,26,28–32,34–36,39,41,42]. In the studies reporting on RC after TMT [7–11,21–25,28–32,34–40,45], there were 360 (17.5%) of 2,053 patients who were subjected to RC after TMT.
Endoscopic Treatment of Bladder Tumors
2016, Endoscopic Diagnosis and Treatment in Urinary Bladder Pathology: Handbook of EndourologyRadical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials
2015, Critical Reviews in Oncology/HematologyA systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC)
2015, Critical Reviews in Oncology/HematologyTrimodality treatment in the conservative management of infiltrating bladder cancer: A critical review of the literature
2013, Critical Reviews in Oncology/Hematology
Copyright © 1997 Published by Elsevier Inc.